Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Halub Medical provides a wide range of clinical and cosmetic healthcare services. It has recently partnered with Helio Genomics to commercialize the blood-based liver cancer diagnostic test "HelioLiver Dx" in Saudi Arabia and the GCC. The pivotal trial of this test demonstrated four times better sensitivity than ultrasound for early detection of liver cancer; it is expected to improve adherence rates significantly due to its non-invasive nature. The company also operates advanced dermatology/aesthetic clinics using state-of-the-art laser technologies and offers rehabilitation services focused on addiction recovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Halub Medical.